Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W4224031477', 'doi': 'https://doi.org/10.1007/s00280-022-04434-2', 'title': 'Assessment of cytochrome P450 3A4-mediated drug–drug interactions for ipatasertib using a fit-for-purpose physiologically based pharmacokinetic model', 'display_name': 'Assessment of cytochrome P450 3A4-mediated drug–drug interactions for ipatasertib using a fit-for-purpose physiologically based pharmacokinetic model', 'publication_year': 2022, 'publication_date': '2022-04-15', 'ids': {'openalex': 'https://openalex.org/W4224031477', 'doi': 'https://doi.org/10.1007/s00280-022-04434-2', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/35428895'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1007/s00280-022-04434-2', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S117498271', 'display_name': 'Cancer Chemotherapy and Pharmacology', 'issn_l': '0344-5704', 'issn': ['0344-5704', '1432-0843'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319900', 'host_organization_name': 'Springer Science+Business Media', 'host_organization_lineage': ['https://openalex.org/P4310319965', 'https://openalex.org/P4310319900'], 'host_organization_lineage_names': ['Springer Nature', 'Springer Science+Business Media'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'hybrid', 'oa_url': 'https://doi.org/10.1007/s00280-022-04434-2', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5044912494', 'display_name': 'Jing Jing', 'orcid': 'https://orcid.org/0000-0003-0916-4901'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jing Jing', 'raw_affiliation_strings': ['Clinical Pharmacology, Genentech, Inc., South San Francisco, CA, USA'], 'affiliations': [{'raw_affiliation_string': 'Clinical Pharmacology, Genentech, Inc., South San Francisco, CA, USA', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100400909', 'display_name': 'Yuan Chen', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Yuan Chen', 'raw_affiliation_strings': ['Clinical Pharmacology, Genentech, Inc., South San Francisco, CA, USA'], 'affiliations': [{'raw_affiliation_string': 'Clinical Pharmacology, Genentech, Inc., South San Francisco, CA, USA', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5022619396', 'display_name': 'Luna Musib', 'orcid': 'https://orcid.org/0000-0002-6476-7919'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Luna Musib', 'raw_affiliation_strings': ['Clinical Pharmacology, Genentech, Inc., South San Francisco, CA, USA'], 'affiliations': [{'raw_affiliation_string': 'Clinical Pharmacology, Genentech, Inc., South San Francisco, CA, USA', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5065578593', 'display_name': 'Jin Y. Jin', 'orcid': 'https://orcid.org/0000-0002-3627-0323'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jin Y. Jin', 'raw_affiliation_strings': ['Clinical Pharmacology, Genentech, Inc., South San Francisco, CA, USA'], 'affiliations': [{'raw_affiliation_string': 'Clinical Pharmacology, Genentech, Inc., South San Francisco, CA, USA', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5078801804', 'display_name': 'Kit Wun Kathy Cheung', 'orcid': 'https://orcid.org/0000-0002-5541-3617'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kit Wun Kathy Cheung', 'raw_affiliation_strings': ['Clinical Pharmacology, Genentech, Inc., South San Francisco, CA, USA'], 'affiliations': [{'raw_affiliation_string': 'Clinical Pharmacology, Genentech, Inc., South San Francisco, CA, USA', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5088638080', 'display_name': 'Kenta Yoshida', 'orcid': 'https://orcid.org/0000-0003-4967-3831'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kenta Yoshida', 'raw_affiliation_strings': ['Clinical Pharmacology, Genentech, Inc., South San Francisco, CA, USA'], 'affiliations': [{'raw_affiliation_string': 'Clinical Pharmacology, Genentech, Inc., South San Francisco, CA, USA', 'institution_ids': []}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5039876591', 'display_name': 'Rucha Sane', 'orcid': 'https://orcid.org/0000-0002-9043-5336'}, 'institutions': [], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Rucha Sane', 'raw_affiliation_strings': ['Clinical Pharmacology, Genentech, Inc., South San Francisco, CA, USA'], 'affiliations': [{'raw_affiliation_string': 'Clinical Pharmacology, Genentech, Inc., South San Francisco, CA, USA', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': {'value': 3290, 'currency': 'EUR', 'value_usd': 3990, 'provenance': 'doaj'}, 'apc_paid': {'value': 3290, 'currency': 'EUR', 'value_usd': 3990, 'provenance': 'doaj'}, 'fwci': 1.048, 'has_fulltext': False, 'cited_by_count': 4, 'citation_normalized_percentile': {'value': 0.999754, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 80, 'max': 83}, 'biblio': {'volume': '89', 'issue': '5', 'first_page': '707', 'last_page': '720'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10375', 'display_name': 'Pharmacogenetics and Drug Metabolism', 'score': 0.9996, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10375', 'display_name': 'Pharmacogenetics and Drug Metabolism', 'score': 0.9996, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10952', 'display_name': 'PI3K/AKT/mTOR signaling in cancer', 'score': 0.9989, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10649', 'display_name': 'Multiple Myeloma Research and Treatments', 'score': 0.9964, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C185867374', 'wikidata': 'https://www.wikidata.org/wiki/Q2562769', 'display_name': 'Physiologically based pharmacokinetic modelling', 'level': 3, 'score': 0.97569513}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.797935}, {'id': 'https://openalex.org/C112705442', 'wikidata': 'https://www.wikidata.org/wiki/Q323936', 'display_name': 'Pharmacokinetics', 'level': 2, 'score': 0.7863028}, {'id': 'https://openalex.org/C109650736', 'wikidata': 'https://www.wikidata.org/wiki/Q424440', 'display_name': 'CYP3A4', 'level': 4, 'score': 0.71528995}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.5118508}, {'id': 'https://openalex.org/C2780035454', 'wikidata': 'https://www.wikidata.org/wiki/Q8386', 'display_name': 'Drug', 'level': 2, 'score': 0.46724322}, {'id': 'https://openalex.org/C526171541', 'wikidata': 'https://www.wikidata.org/wiki/Q407693', 'display_name': 'Cytochrome P450', 'level': 3, 'score': 0.3122891}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.30339956}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C62231903', 'wikidata': 'https://www.wikidata.org/wiki/Q1057', 'display_name': 'Metabolism', 'level': 2, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D051544', 'descriptor_name': 'Cytochrome P-450 CYP3A', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D065692', 'descriptor_name': 'Cytochrome P-450 CYP3A Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D003198', 'descriptor_name': 'Computer Simulation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D065701', 'descriptor_name': 'Cytochrome P-450 CYP3A Inducers', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004347', 'descriptor_name': 'Drug Interactions', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008954', 'descriptor_name': 'Models, Biological', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010879', 'descriptor_name': 'Piperazines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011743', 'descriptor_name': 'Pyrimidines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 3, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1007/s00280-022-04434-2', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S117498271', 'display_name': 'Cancer Chemotherapy and Pharmacology', 'issn_l': '0344-5704', 'issn': ['0344-5704', '1432-0843'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319900', 'host_organization_name': 'Springer Science+Business Media', 'host_organization_lineage': ['https://openalex.org/P4310319965', 'https://openalex.org/P4310319900'], 'host_organization_lineage_names': ['Springer Nature', 'Springer Science+Business Media'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9054915', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/35428895', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1007/s00280-022-04434-2', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S117498271', 'display_name': 'Cancer Chemotherapy and Pharmacology', 'issn_l': '0344-5704', 'issn': ['0344-5704', '1432-0843'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319900', 'host_organization_name': 'Springer Science+Business Media', 'host_organization_lineage': ['https://openalex.org/P4310319965', 'https://openalex.org/P4310319900'], 'host_organization_lineage_names': ['Springer Nature', 'Springer Science+Business Media'], 'type': 'journal'}, 'license': 'cc-by', 'license_id': 'https://openalex.org/licenses/cc-by', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being', 'score': 0.5}], 'grants': [{'funder': 'https://openalex.org/F4320332193', 'funder_display_name': 'Genentech', 'award_id': None}], 'datasets': [], 'versions': [], 'referenced_works_count': 20, 'referenced_works': ['https://openalex.org/W1999742630', 'https://openalex.org/W2001208964', 'https://openalex.org/W2061818721', 'https://openalex.org/W2097773105', 'https://openalex.org/W2161655114', 'https://openalex.org/W2162409477', 'https://openalex.org/W2169866093', 'https://openalex.org/W2269712095', 'https://openalex.org/W2467399654', 'https://openalex.org/W2519782392', 'https://openalex.org/W2578326055', 'https://openalex.org/W2593641295', 'https://openalex.org/W2606513998', 'https://openalex.org/W2884876277', 'https://openalex.org/W2899444542', 'https://openalex.org/W2935153017', 'https://openalex.org/W3007341696', 'https://openalex.org/W3098681737', 'https://openalex.org/W3165777387', 'https://openalex.org/W3197886046'], 'related_works': ['https://openalex.org/W4384818288', 'https://openalex.org/W4308352595', 'https://openalex.org/W4285550049', 'https://openalex.org/W4224287573', 'https://openalex.org/W3212117736', 'https://openalex.org/W2359517566', 'https://openalex.org/W2311986450', 'https://openalex.org/W2068005011', 'https://openalex.org/W2034505552', 'https://openalex.org/W2000200648'], 'abstract_inverted_index': {'Abstract': [0], 'Purpose': [1], 'Ipatasertib,': [2], 'a': [3, 22, 25, 64, 131, 139, 153, 183, 193, 207], 'potent': [4], 'and': [5, 24, 62, 88, 91, 94, 108, 147, 149, 169, 179, 218], 'highly': [6], 'selective': [7], 'small-molecule': [8], 'inhibitor': [9, 27], 'of': [10, 18, 28, 48, 55, 71, 106, 112, 120, 134, 162, 205, 227], 'AKT,': [11], 'is': [12, 21], 'currently': [13], 'under': [14], 'investigation': [15], 'for': [16, 216, 223], 'treatment': [17], 'cancer.': [19], 'Ipatasertib': [20], 'substrate': [23], 'time-dependent': [26], 'CYP3A4.': [29], 'It': [30], 'exhibits': [31], 'non-linear': [32, 104], 'pharmacokinetics': [33, 105], 'at': [34, 50], 'subclinical': [35], 'doses': [36, 119], 'in': [37, 81, 84, 86, 159, 196], 'the': [38, 45, 51, 110, 113, 127, 160, 185, 203, 213, 224], 'clinical': [39, 53, 89, 97, 115, 214], 'dose': [40, 54], 'escalation': [41], 'study.': [42], 'To': [43], 'assess': [44, 212], 'DDI': [46], 'risk': [47], 'ipatasertib': [49, 72, 107, 123, 135, 171, 189, 217], 'intended': [52], '400': [56, 121], 'mg': [57, 122], 'with': [58, 137, 142, 152], 'CYP3A4': [59, 144, 155, 166, 229], 'inhibitors,': [60, 145], 'inducers,': [61, 167], 'substrates,': [63], 'fit-for-purpose': [65, 208], 'physiologically': [66], 'based': [67], 'pharmacokinetic': [68], '(PBPK)': [69], 'model': [70, 78, 102, 129, 186, 210], 'was': [73, 79, 92], 'developed.': [74], 'Methods': [75], 'The': [76, 100], 'PBPK': [77, 101, 128, 209], 'constructed': [80], 'Simcyp': [82], 'using': [83, 96, 206], 'silico,': [85], 'vitro,': [87], 'data': [90], 'optimized': [93], 'verified': [95], 'data.': [98], 'Results': [99], 'described': [103], 'captured': [109], 'magnitude': [111], 'observed': [114], 'DDIs.': [116], 'Following': [117], 'repeated': [118], 'once': [124], 'daily': [125], '(QD),': [126], 'predicted': [130, 174, 187], '3.3-fold': [132], 'increase': [133, 141, 195], 'exposure': [136], 'itraconazole;': [138], '2–2.5-fold': [140], 'moderate': [143, 165], 'erythromycin': [146], 'diltiazem;': [148], 'no': [150], 'change': [151], 'weak': [154], 'inhibitor,': [156], 'fluvoxamine.': [157], 'Additionally,': [158], 'presence': [161], 'strong': [163], 'or': [164, 231], 'rifampicin': [168], 'efavirenz,': [170], 'exposures': [172], 'were': [173], 'to': [175, 211, 219], 'decrease': [176], 'by': [177], '86%': [178], '74%,': [180], 'respectively.': [181], 'As': [182], 'perpetrator,': [184], 'that': [188], '(400': [190], 'mg)': [191], 'caused': [192], '1.7-fold': [194], 'midazolam': [197], 'exposure.': [198], 'Conclusion': [199], 'This': [200], 'study': [201], 'demonstrates': [202], 'value': [204], 'DDIs': [215], 'provide': [220], 'dosing': [221], 'strategies': [222], 'concurrent': [225], 'use': [226], 'other': [228], 'perpetrators': [230], 'victims.': [232]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4224031477', 'counts_by_year': [{'year': 2024, 'cited_by_count': 1}, {'year': 2023, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 2}], 'updated_date': '2024-12-24T05:00:54.846839', 'created_date': '2022-04-19'}